Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies
暂无分享，去创建一个
T. Choueiri | G. Sonpavde | G. Bubley | A. Venkatesan | B. McGregor | A. Siefker-Radtke | M. Campbell | A. Shah | A. Choudhury | W. Xie | R. McKay | K. Kilbridge | M. Bilen | A. Mortazavi | A. Schmidt | S. Farah